Karan L Chohan

7PUBLICATIONS
45CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyHumoural immunology and immunochemistryMajor global burdens of diseaseHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 02, 2026
Long-term clinical outcomes from the smart start trial: rituximab, lenalidomide and ibrutinib in patients with newly diagnosed large B-cell lymphoma.

|May 22, 2026
Clinical outcomes of CD3xCD20 bispecific antibodies in patients with central nervous system involvement by lymphoma.

|Dec 03, 2025
Long-term outcomes and treatment patterns in Waldenström macroglobulinemia patients who discontinue Bruton tyrosine kinase inhibitor (BTKi) therapy.

Karan L Chohan, Lorenzo Gensini, Sherif Seif

|May 14, 2025
Phase I study of pomalidomide in relapsed or refractory Waldenström macroglobulinaemia.

Karan L Chohan, Donna M Weber, Lei Feng

|Mar 22, 2024
Clinical implications of frailty assessed in hospitalized patients with acute-exacerbation of interstitial lung disease.

Marine Van Hollebeke, Karan Chohan, Colin J Adams

|Nov 30, 2023
Real-world associations of cytokine release syndrome and neurotoxicity with efficacy in patients receiving anti-CD-19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: the Mayo Clinic experience.

Karan L Chohan, Radhika Bansal, Matthew A Hathcock

Pageof 2

Frequent Collaborators

2 joint publications

Sairah Ahmed

2 joint publications

Robert Z Orlowski

1 joint publications

Marine Van Hollebeke

1 joint publications

Colin J Adams